ClinicalTrials.Veeva

Menu

Bilateral Uterine Artery Ligation in Reducing Incidence of Postpartum Hemorrhage in Cesarean Section

A

Assiut University

Status

Completed

Conditions

Post Partum Hemorrhage

Treatments

Drug: Oxytocin
Procedure: bilateral uterine artery ligation

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The patients were recruited from women attending labor ward to undergo cesarean section.

Enrollment

1,070 patients

Sex

Female

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women with one or more of the following conditions undergoing cesarean section for obstetric indication were included:
  • Maternal anemia (not less than 7 gm %).
  • Macrosomic baby >4kgs.
  • Twin pregnancy and high order pregnancy.
  • Polyhydramnios.
  • Grand multipara.
  • Previous history of atonic postpartum hemorrhage.
  • Prolonged vaginal delivery.
  • Emergency cesarean.
  • Chorioamnionitis.

Exclusion criteria

    • Placenta previa.
  • Patients with bleeding tendency (congenital or acquired)
  • Ante-partum hemorrhage.
  • Patients with no risk for uterine atony.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

1,070 participants in 2 patient groups

study group
Experimental group
Description:
patients at risk of uterine atony undergoing cesarean section underwent bilateral uterine artery ligation and received oxytocin.
Treatment:
Procedure: bilateral uterine artery ligation
Drug: Oxytocin
control group
Active Comparator group
Description:
patients at risk of uterine atony undergoing cesarean section received oxytocin only.
Treatment:
Drug: Oxytocin

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems